SCHEMBL2113442

SCHEMBL2113442

O=c1[nH]c(NCOCCO)nc2nc[nH]c12

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
XDH P47989 3/20 0.57
GDA Q9Y2T3 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2346371 0.90 XDH (0.62) XDHGDA
SCHEMBL10421282 0.88 XDH (0.70) XDHGDA
SCHEMBL8864963 0.86 XDH (0.54) XDHGDA
SCHEMBL1767753 0.85 XDH (0.66) XDHGDA
SCHEMBL29514994 0.84 XDH (0.52) XDHGDA
SCHEMBL6751934 0.83 XDH (0.71) XDHGDA
SCHEMBL2249905 0.83 XDH (0.54) XDHGDA
SCHEMBL28721442 0.83 XDH (0.74) XDHGDA
SCHEMBL2343363 0.82 XDH (0.65) XDHGDA
SCHEMBL3512361 0.82 XDH (0.55) XDHGDA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119403836-A Methods for eliminating myeloid-derived suppressor cells using NEO-201 antibodies 精密生物制品股份有限公司 2025-02-07 CN claimed
CN-100531736-C Application of 9 - (2 - hydroxyethoxy methyl)guanine in preparing silkworm drug YUANDUO ZHOU (CN) 2009-08-26 CN claimed
CN-101091712-A Application of 9 - (2 - hydroxyethoxy methyl) in preparing silkworm drug YUANDUO ZHOU (CN) 2007-12-26 CN claimed
US-RE38341-E1 Method for electrokinetic delivery of medicaments BIOPHORETIC THERAPEUTIC SYSTEMS, LLC 2003-12-09 US claimed
EP-0531452-A4 SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES 1993-06-09 EP claimed
EP-0531452-A1 SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES NeXstar Pharmaceuticals, Inc. (US) 1993-03-17 EP claimed
WO-1991018914-A1 SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES VICAL, INC. (US) 1991-12-12 WO claimed
CN-119403836-A Methods for eliminating myeloid-derived suppressor cells using NEO-201 antibodies 精密生物制品股份有限公司 2025-02-07 CN disclosed
EP-4499710-A1 METHODS FOR ABLATING MYELOID DERIVED SUPPRESSOR CELLS USING NEO-201 ANTIBODY Precision Biologics, Inc. (US) 2025-02-05 EP disclosed
WO-2023244141-A1 ANTIVIRAL PREPARATION FOR INJECTION ХАБЕЕВ, Ренат Рушанович 2023-12-21 WO disclosed
WO-2023225608-A1 METHODS FOR ABLATING MYELOID DERIVED SUPPRESSOR CELLS USING NEO-201 ANTIBODY PRECISION BIOLOGICS, INC. (US) 2023-11-23 WO disclosed
CN-116528851-A Pharmaceutical formulation of griseofulvin for long-term ocular delivery 普渡研究基金会 2023-08-01 CN disclosed
EP-4126960-A1 METHODS AND COMBINATIONS FOR DUAL TARGETING OF TNF FAMILY MEMBERS La Jolla Institute for Immunology (US) 2023-02-08 EP disclosed
EP-0272446-B1 NOVEL ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1992-11-11 EP disclosed
EP-0410660-A1 Cyclopentane derivatives GLAXO GROUP LIMITED (GB) 1991-01-30 EP disclosed
EP-0145739-B1 NOVEL ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1989-02-08 EP disclosed
EP-0274025-A2 Novel antiviral agents SRI INTERNATIONAL (US) 1988-07-13 EP disclosed
EP-0273169-A2 Novel antiviral agents SRI INTERNATIONAL (US) 1988-07-06 EP disclosed
EP-0272446-A1 Novel antiviral agents SRI INTERNATIONAL (US) 1988-06-29 EP disclosed
WO-1984004748-A2 NOVEL ANTIVIRAL AGENTS 1984-12-06 WO disclosed